Vanguard Group Inc. Has $439.26 Million Stock Holdings in Maximus, Inc. (NYSE:MMS)

Key Points

• Vanguard Group Inc. has reduced its stake in Maximus, Inc. by 1.6%, holding approximately $439.26 million worth of shares after selling 106,630 in the first quarter.
• Maximus reported a quarterly EPS of $2.16, exceeding analysts' expectations of $1.39, with revenue increasing to $1.35 billion compared to $1.29 billion forecasted.
• The company declared a quarterly dividend of $0.30, with an annualized yield of 1.4%, set to be paid on August 31st to investors of record by August 15th.

Vanguard Group Inc. lowered its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 1.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,441,654 shares of the health services provider's stock after selling 106,630 shares during the quarter. Vanguard Group Inc. owned 11.38% of Maximus worth $439,256,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of MMS. SG Capital Management LLC acquired a new position in Maximus during the 4th quarter worth approximately $30,285,000. Reinhart Partners LLC. boosted its position in Maximus by 65.4% during the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock worth $62,156,000 after acquiring an additional 360,365 shares during the last quarter. Squarepoint Ops LLC acquired a new position in Maximus during the 4th quarter worth approximately $22,661,000. Voloridge Investment Management LLC boosted its position in Maximus by 306.8% during the 4th quarter. Voloridge Investment Management LLC now owns 376,055 shares of the health services provider's stock worth $28,073,000 after acquiring an additional 283,608 shares during the last quarter. Finally, AQR Capital Management LLC boosted its position in Maximus by 189.1% during the 4th quarter. AQR Capital Management LLC now owns 423,298 shares of the health services provider's stock worth $31,599,000 after acquiring an additional 276,859 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Trading Down 0.2%

Shares of Maximus stock opened at $84.31 on Friday. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.94. The stock has a market cap of $4.75 billion, a P/E ratio of 15.53 and a beta of 0.60. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The business's 50 day moving average is $73.03 and its 200-day moving average is $70.73.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%. The company had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter in the prior year, the business posted $1.74 EPS. The business's revenue was up 2.5% compared to the same quarter last year. Equities research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, August 15th. Maximus's dividend payout ratio is 22.10%.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Insiders Place Their Bets

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director owned 14,205 shares in the company, valued at $1,028,157.90. This trade represents a 35.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.60% of the company's stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.